
Carmat SA
PAR:ALCAR

Carmat SA?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.777
4.1788
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Carmat SA hold over its rivals?
What risks and challenges
does Carmat SA face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Carmat SA.
Provide an overview of the primary business activities
of Carmat SA.
What unique competitive advantages
does Carmat SA hold over its rivals?
What risks and challenges
does Carmat SA face in the near future?
Has there been any significant insider trading activity
in Carmat SA recently?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Carmat SA.
Provide P/S
for Carmat SA.
Provide P/E
for Carmat SA.
Provide P/OCF
for Carmat SA.
Provide P/FCFE
for Carmat SA.
Provide P/B
for Carmat SA.
Provide EV/S
for Carmat SA.
Provide EV/GP
for Carmat SA.
Provide EV/EBITDA
for Carmat SA.
Provide EV/EBIT
for Carmat SA.
Provide EV/OCF
for Carmat SA.
Provide EV/FCFF
for Carmat SA.
Provide EV/IC
for Carmat SA.
Show me price targets
for Carmat SA made by professional analysts.
What are the Revenue projections
for Carmat SA?
How accurate were the past Revenue estimates
for Carmat SA?
What are the Net Income projections
for Carmat SA?
How accurate were the past Net Income estimates
for Carmat SA?
What are the EPS projections
for Carmat SA?
How accurate were the past EPS estimates
for Carmat SA?
What are the EBIT projections
for Carmat SA?
How accurate were the past EBIT estimates
for Carmat SA?
Compare the revenue forecasts
for Carmat SA with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Carmat SA and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Carmat SA against its competitors.
Analyze the profit margins
(gross, operating, and net) of Carmat SA compared to its peers.
Compare the P/E ratios
of Carmat SA against its peers.
Discuss the investment returns and shareholder value creation
comparing Carmat SA with its peers.
Analyze the financial leverage
of Carmat SA compared to its main competitors.
Show all profitability ratios
for Carmat SA.
Provide ROE
for Carmat SA.
Provide ROA
for Carmat SA.
Provide ROIC
for Carmat SA.
Provide ROCE
for Carmat SA.
Provide Gross Margin
for Carmat SA.
Provide Operating Margin
for Carmat SA.
Provide Net Margin
for Carmat SA.
Provide FCF Margin
for Carmat SA.
Show all solvency ratios
for Carmat SA.
Provide D/E Ratio
for Carmat SA.
Provide D/A Ratio
for Carmat SA.
Provide Interest Coverage Ratio
for Carmat SA.
Provide Altman Z-Score Ratio
for Carmat SA.
Provide Quick Ratio
for Carmat SA.
Provide Current Ratio
for Carmat SA.
Provide Cash Ratio
for Carmat SA.
What is the historical Revenue growth
over the last 5 years for Carmat SA?
What is the historical Net Income growth
over the last 5 years for Carmat SA?
What is the current Free Cash Flow
of Carmat SA?
Discuss the annual earnings per share (EPS)
trend over the past five years for Carmat SA.
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
FR |
![]() |
Carmat SA
PAR:ALCAR
|
50m EUR | -0.9 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
218.1B USD | 16.3 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
173.9B USD | 74.9 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
138.7B USD | 74.8 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
132.1B USD | 44.1 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
105.7B USD | 24.8 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
58.7B USD | 33.6 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
50.2B EUR | 25.3 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
41.6B USD | 10 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
259.6B CNY | 21 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
32.8B USD | 36.9 |
|
Earnings Growth | PEG | |||||
---|---|---|---|---|---|---|
FR |
![]() |
Carmat SA
PAR:ALCAR
|
Average P/E:
36.2
|
N/A | N/A | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
16.3
|
-6%
|
N/A |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
74.9
|
20%
|
3.7 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
74.8
|
44%
|
1.7 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
44.1
|
28%
|
1.6 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
24.8
|
30%
|
0.8 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
33.6
|
42%
|
0.8 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
25.3
|
23%
|
1.1 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
10
|
-24%
|
N/A |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
21
|
15%
|
1.4 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
36.9
|
13%
|
2.8 |
|
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.